RU2006108528A - Производные 2-алкилиден-19-нор-витамина d для лечения остеопении или мужского остеопороза - Google Patents
Производные 2-алкилиден-19-нор-витамина d для лечения остеопении или мужского остеопороза Download PDFInfo
- Publication number
- RU2006108528A RU2006108528A RU2006108528/14A RU2006108528A RU2006108528A RU 2006108528 A RU2006108528 A RU 2006108528A RU 2006108528/14 A RU2006108528/14 A RU 2006108528/14A RU 2006108528 A RU2006108528 A RU 2006108528A RU 2006108528 A RU2006108528 A RU 2006108528A
- Authority
- RU
- Russia
- Prior art keywords
- treatment
- osteopenia
- alkyliden
- vitamin
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Claims (6)
1. Способ лечения остеопении или мужского остеопороза, включающий введение нуждающемуся в таком лечении пациенту терапевтически эффективного количества 2-метилен-19-нор-20(S)-1б,25-дигидроксивитамина D3.
2. Способ по п.1, где 2-метилен-19-нор-20(S)-1б,25-дигидроксивитамин D3 вводят перорально.
3. Способ по п.1, где 2-метилен-19-нор-20(S)-1б,25-дигидроксивитамин D3 вводят парентерально.
4. Способ по п.1, где 2-метилен-19-нор-20(S)-1б,25-дигидроксивитамин D3 вводят трансдермально.
5. Способ по п.1, где проводится лечение остеопении.
6. Способ по п.1, где проводится лечение мужского остеопороза.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50450803P | 2003-09-19 | 2003-09-19 | |
| US60/504,508 | 2003-09-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2006108528A true RU2006108528A (ru) | 2006-07-27 |
Family
ID=34375510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2006108528/14A RU2006108528A (ru) | 2003-09-19 | 2004-09-06 | Производные 2-алкилиден-19-нор-витамина d для лечения остеопении или мужского остеопороза |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20050065125A1 (ru) |
| EP (1) | EP1667690A1 (ru) |
| JP (1) | JP2007505884A (ru) |
| KR (1) | KR20060058135A (ru) |
| CN (1) | CN100413507C (ru) |
| AU (1) | AU2004273667A1 (ru) |
| BR (1) | BRPI0414465A (ru) |
| CA (1) | CA2539358A1 (ru) |
| HK (1) | HK1092063A1 (ru) |
| IL (1) | IL173653A0 (ru) |
| MX (1) | MXPA06003156A (ru) |
| NO (1) | NO20060655L (ru) |
| NZ (1) | NZ545393A (ru) |
| RU (1) | RU2006108528A (ru) |
| TW (1) | TW200512000A (ru) |
| WO (1) | WO2005027917A1 (ru) |
| ZA (1) | ZA200602258B (ru) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1861419B1 (en) | 2005-03-15 | 2011-06-29 | Allergan, Inc. | Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems |
| US20120207742A1 (en) | 2011-02-14 | 2012-08-16 | Allergan, Inc. | Treatments Using PSMA Ligand Endopeptidases |
| CN106974078A (zh) * | 2017-03-22 | 2017-07-25 | 广东海洋大学 | 25‑oh‑d3促进21‑42日龄白羽肉鸡胫骨发育的应用 |
| CN106857403A (zh) * | 2017-03-22 | 2017-06-20 | 广东海洋大学 | 25‑oh‑d3促进1‑21日龄白羽肉鸡胫骨发育的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5086191A (en) * | 1991-05-28 | 1992-02-04 | Wisconsin Alumni Research Foundation | Intermediates for the synthesis of 19-nor vitamin D compounds |
| JP2898882B2 (ja) * | 1993-04-05 | 1999-06-02 | ウイスコンシン アラムナイ リサーチ フオンデーシヨン | ２−位に置換基を有する１９−ノル−ビタミンｄ３ 化合物 |
| US6316642B1 (en) * | 1997-03-17 | 2001-11-13 | Wisconsin Alumni Research Foundation | 26,27-Homologated-20-EPI-2alkyl-19-nor-vitamin D compounds |
| US5843928A (en) * | 1997-03-17 | 1998-12-01 | Wisconsin Alumni Research Foundation | 2-alkylidene-19-nor-vitamin D compounds |
| DE19935771A1 (de) * | 1999-07-23 | 2001-02-01 | Schering Ag | Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln |
| AU776755B2 (en) * | 2000-01-31 | 2004-09-23 | Leo Pharma A/S | Use of vitamin D-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin D3-derivatives |
| NZ522909A (en) * | 2000-05-31 | 2004-09-24 | Wisconsin Alumni Res Found | 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| US20030195175A1 (en) * | 2002-03-25 | 2003-10-16 | Deluca Hector F. | Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone |
-
2004
- 2004-09-06 JP JP2006526716A patent/JP2007505884A/ja active Pending
- 2004-09-06 WO PCT/IB2004/002912 patent/WO2005027917A1/en active Application Filing
- 2004-09-06 CN CNB200480026946XA patent/CN100413507C/zh not_active Expired - Fee Related
- 2004-09-06 MX MXPA06003156A patent/MXPA06003156A/es unknown
- 2004-09-06 KR KR1020067005462A patent/KR20060058135A/ko not_active Application Discontinuation
- 2004-09-06 CA CA002539358A patent/CA2539358A1/en not_active Abandoned
- 2004-09-06 EP EP04769311A patent/EP1667690A1/en not_active Ceased
- 2004-09-06 RU RU2006108528/14A patent/RU2006108528A/ru unknown
- 2004-09-06 NZ NZ545393A patent/NZ545393A/en unknown
- 2004-09-06 BR BRPI0414465-1A patent/BRPI0414465A/pt not_active IP Right Cessation
- 2004-09-06 AU AU2004273667A patent/AU2004273667A1/en not_active Abandoned
- 2004-09-15 TW TW093127917A patent/TW200512000A/zh unknown
- 2004-09-16 US US10/942,377 patent/US20050065125A1/en not_active Abandoned
-
2006
- 2006-02-09 NO NO20060655A patent/NO20060655L/no not_active Application Discontinuation
- 2006-02-09 IL IL173653A patent/IL173653A0/en unknown
- 2006-03-17 ZA ZA200602258A patent/ZA200602258B/en unknown
- 2006-11-23 HK HK06112845.6A patent/HK1092063A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ545393A (en) | 2009-10-30 |
| IL173653A0 (en) | 2006-07-05 |
| CN1852717A (zh) | 2006-10-25 |
| EP1667690A1 (en) | 2006-06-14 |
| TW200512000A (en) | 2005-04-01 |
| BRPI0414465A (pt) | 2006-11-14 |
| ZA200602258B (en) | 2007-11-28 |
| MXPA06003156A (es) | 2006-06-05 |
| HK1092063A1 (en) | 2007-02-02 |
| NO20060655L (no) | 2006-06-16 |
| CA2539358A1 (en) | 2005-03-31 |
| WO2005027917A1 (en) | 2005-03-31 |
| US20050065125A1 (en) | 2005-03-24 |
| AU2004273667A1 (en) | 2005-03-31 |
| JP2007505884A (ja) | 2007-03-15 |
| KR20060058135A (ko) | 2006-05-29 |
| CN100413507C (zh) | 2008-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0308904A (pt) | Método de tratamento de gastroparesia, e, uso de um composto de glp-1 | |
| BR0315337A (pt) | Composto, formulação farmacêutica, e, método para tratar câncer | |
| NO20050204L (no) | Kombinasjoner av legemidler for behandling av neoplasmer | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| EA200600820A1 (ru) | Способы лечения, модификации и устранения боли с использованием 1-оксо-2-(2,6-диоксопиперидин-3-ил)-4-метилизоиндолина | |
| NO20061325L (no) | Kombinasjon av legemidler for behandling av neoplasmer | |
| GB0225475D0 (en) | Therapeutic agents | |
| HK1086186A1 (en) | Use of spongosine (2-methoxyadenosein) for preparing pharmaceutical for the treatment of pain | |
| WO2003079979A3 (en) | Method for treating congestive heart failure | |
| BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
| CO5670328A2 (es) | Composiciones farmaceuticas y procedimientos que comprenden combinaciones de derivados de 2-alquiliden-19-nor-vitamina d y un agonista/antagonista de estrogenos | |
| GB0130677D0 (en) | Medicaments and novel compounds | |
| BRPI0411324A (pt) | composições farmacêuticas e métodos de tratamento de resposta mediada por histamina em pacientes | |
| RU2006108528A (ru) | Производные 2-алкилиден-19-нор-витамина d для лечения остеопении или мужского остеопороза | |
| NO20042758L (no) | Fremgangsmate for behandling av en pasient som krever analgesi. | |
| WO2007047893A3 (en) | Use of dasatinib for the treatment of bone metastasis | |
| RU2004112422A (ru) | Роувастатин в преддеменционных состояниях | |
| RU2006107649A (ru) | Производные 2-алкилиден-19-нор-витамина d для лечения слабости, поражения мышц или саркопении | |
| IT1320192B1 (it) | Composizione terapeutica per la cura della psoriasi. | |
| SE0100873D0 (sv) | Method of treatment | |
| CA2403674A1 (en) | The use of t3 for treating congestive heart failure | |
| RU2005131943A (ru) | Лечебные и/или профилактические средства для хронических болезней кожи | |
| ATE366579T1 (de) | Verfahren zur behandlung von leberkrebs durch intrahepatische verabreichung von nemorubicin | |
| RU2000108520A (ru) | Способ восстановительного лечения больных остеоартрозом | |
| RU2000117903A (ru) | Способ лечения хронического гастрита и язвенной болезни двенадцатиперстной кишки |